Cargando…
Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511819/ https://www.ncbi.nlm.nih.gov/pubmed/32979837 http://dx.doi.org/10.1016/j.ebiom.2020.103001 |
_version_ | 1783586032736796672 |
---|---|
author | Qi, Zhaolai Zhang, Ting Song, Lei Fu, Hongyong Luo, Haifeng Wu, Jie Zhao, Shuyun Zhang, Tianhua Guo, Lianying Jin, Lingling Zhang, He Huang, Gena Ma, Tonghui Wu, Yingjie Huang, Lin |
author_facet | Qi, Zhaolai Zhang, Ting Song, Lei Fu, Hongyong Luo, Haifeng Wu, Jie Zhao, Shuyun Zhang, Tianhua Guo, Lianying Jin, Lingling Zhang, He Huang, Gena Ma, Tonghui Wu, Yingjie Huang, Lin |
author_sort | Qi, Zhaolai |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7511819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75118192020-09-28 Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] Qi, Zhaolai Zhang, Ting Song, Lei Fu, Hongyong Luo, Haifeng Wu, Jie Zhao, Shuyun Zhang, Tianhua Guo, Lianying Jin, Lingling Zhang, He Huang, Gena Ma, Tonghui Wu, Yingjie Huang, Lin EBioMedicine Corrigendum Elsevier 2020-09-23 /pmc/articles/PMC7511819/ /pubmed/32979837 http://dx.doi.org/10.1016/j.ebiom.2020.103001 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Corrigendum Qi, Zhaolai Zhang, Ting Song, Lei Fu, Hongyong Luo, Haifeng Wu, Jie Zhao, Shuyun Zhang, Tianhua Guo, Lianying Jin, Lingling Zhang, He Huang, Gena Ma, Tonghui Wu, Yingjie Huang, Lin Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] |
title | Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] |
title_full | Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] |
title_fullStr | Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] |
title_full_unstemmed | Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] |
title_short | Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604] |
title_sort | corrigendum to ‘pras40 hyperexpression promotes hepatocarcinogenesis’ [ebiomedicine 51 (2020) 102,604] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511819/ https://www.ncbi.nlm.nih.gov/pubmed/32979837 http://dx.doi.org/10.1016/j.ebiom.2020.103001 |
work_keys_str_mv | AT qizhaolai corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT zhangting corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT songlei corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT fuhongyong corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT luohaifeng corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT wujie corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT zhaoshuyun corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT zhangtianhua corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT guolianying corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT jinlingling corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT zhanghe corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT huanggena corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT matonghui corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT wuyingjie corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 AT huanglin corrigendumtopras40hyperexpressionpromoteshepatocarcinogenesisebiomedicine512020102604 |